Clinical Trials Logo

Surgical Wound Infection clinical trials

View clinical trials related to Surgical Wound Infection.

Filter by:

NCT ID: NCT05625373 Recruiting - Clinical trials for Postoperative Complications

The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection

Start date: October 25, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

The study will be a pilot randomized control trial with a 1:1 patient randomization of vancomycin powder placement at the time of surgery (compared to no vancomycin placement) with the goal of reducing postoperative complications in patients undergoing an inguinal lymph node dissection for vulvar cancer. The primary objective is to measure the composite rate of postoperative complications within 30 days of inguinal lymph node dissection in patients with vulvar cancer.

NCT ID: NCT05586776 Recruiting - Clinical trials for Surgical Site Infection

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

DECREASE SSI
Start date: January 17, 2023
Phase: Phase 4
Study type: Interventional

The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700 participants randomized 1:1) clinical trial to reduce post-discharge surgical site infection following open colon or small bowel surgery by comparing chlorhexidine bathing plus nasal mupirocin in the 30 days following discharge to soap without antiseptic properties (placebo) and placebo nasal ointment. This trial seeks to enhance the care of the 675,000 patients annually who undergo colon and small bowel surgery by finding simple and efficacious interventions to reduce SSI.

NCT ID: NCT05523713 Recruiting - Hepatectomy Clinical Trials

Development and Validation of a Predictive Score for Surgical Site Infections

SPRED
Start date: October 6, 2022
Phase: Phase 3
Study type: Interventional

More than 8 millions surgical interventions are carried out each year in France. Postoperative complications, in particular infectious, can occur in 10 to 60% of cases and are the cause of postoperative revision in 30% of cases, an increase in mortality, length of stay, readmissions and lead to significant additional socio-economic costs. Currently, improvements in surgical practices have not reduced the incidence of surgical site complications. In this context, the development of predictive scores for the risk of post-operative complication becomes urgent in order to implement new interventions (pre-habilitation) or to modify surgical decisions (timing, approach) in order to reduce the risk of complications before surgery. Several recent studies highlights the importance of the immune response in postoperative prognosis. In particular, an imbalance between the adaptive and innate response involving MDSCs has been demonstrated in patients with postoperative complications.Thanks to new techniques for analyzing the immune system, in-depth analysis of the immune system before surgery is a very promising approach aimed at identifying predictive biomarkers of postoperative prognosis. Our team has developed and patented a multivariate model integrating mass cytometry data, proteomics and clinical data collected before surgery to accurately predict the occurrence of a surgical site complication (AUC = 0.94, p<10e-7) in a monocentric cohort of 43 patients to major abdominal surgery (Stanford University). The objective of the present study is to generalize and validate this preoperative predictive score of infectious complications of the surgical site in the 30 days following major digestive surgery on a larger workforce within a multicenter cohort and to validate this score at using a machine learning method.

NCT ID: NCT05502380 Recruiting - Clinical trials for Surgical Site Infection

Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery

BAPTIST
Start date: September 15, 2022
Phase: Phase 3
Study type: Interventional

The perioperative antibiotic prophylaxis is evidence-based in orthopedic surgery. While its duration ranges from a single dose to three doses throughout the world, the choice of the prophylactic agents is undisputed. Worldwide, the surgeons use 1st or 2nd-generation cephalosporins (or vancomycin in some cases). However, there are particular clinical situation with a high risk of antibiotic-resistant surgical site infections (SSI); independently of the duration of adminis-tered prophylaxis. These resistant SSI's occur in contaminated wounds, or during surgery under current therapeutic antibiotics, and base on "selection" by antibiotics used for therapy or for prophylaxis.

NCT ID: NCT05499481 Recruiting - Clinical trials for Antibiotic Side Effect

Short Against Long Antibiotic Therapy for Infected Orthopedic Sites

SALATIO
Start date: September 15, 2022
Phase: Phase 3
Study type: Interventional

The investigators will perform two concomitant RCTs, depending on the presence of infected osteosynthesis material at enrolment: - SALATIO 1. Infected implant not removed (or new material inserted): Randomization 6 vs. 12 weeks (+/- 5 days) of total antibiotic therapy counted since the first debridement for infection. Early switch to oral targeted therapy. - SALATIO 2. Infected implant without residual material (definitive removal or within the interval of a two-stage exchange): Randomization 3 vs. 6 weeks (+/- 5 days) of total antibiotic therapy counted since the first debridement for infection. Early switch to oral targeted therapy.

NCT ID: NCT05470816 Recruiting - Dementia Clinical Trials

Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial

TRIGS-D
Start date: November 1, 2022
Phase: Phase 3
Study type: Interventional

Prophylactic TxA administration in patients undergoing major gastrointestinal surgery reduces the incidence of delirium after surgery when compared with placebo. The unifying hypothesis is that systemic and neuro-inflammation lead to neuronal injury and resultant postoperative delirium.

NCT ID: NCT05458518 Recruiting - Clinical trials for Cesarean Section Complications

Caesarean Wound Dressing Removal Study

Cesarean
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

An open labelled randomised trial on the timing of wound dressing removal for emergency caesarean delivery in labour.

NCT ID: NCT05455710 Recruiting - Clinical trials for Surgical Wound Infection

Evaluation of Post-discharge Surveillance Mobile Application for Surgical Site Infection

Start date: March 16, 2023
Phase: N/A
Study type: Interventional

Objective: evaluate the effectiveness and usability of a mobile application for post-discharge surveillance of surgical site infection as a support system for clinical decision.

NCT ID: NCT05447559 Recruiting - Clinical trials for Surgical Site Infection

Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study

CALIPSO
Start date: February 7, 2023
Phase: Phase 4
Study type: Interventional

This multicentre, adaptive, pragmatic, double-blind, three-arm, placebo-controlled, randomised, non-inferiority clinical trial will compare the incidence of surgical site infection and other healthcare associated infections, health economic and microbiological impact after intraoperative only (Arm A), to 24 hours (Arm B) and, to 48 hours (Arm C) of IV cefazolin and placebo postoperative surgical antimicrobial prophylaxis in patients undergoing cardiac surgery

NCT ID: NCT05434182 Recruiting - Clinical trials for Surgical Site Infection

Intradermal Suture Versus Stapling for Groin Skin Closure in Vascular Surgery (VASC-INF Trial)

Start date: March 4, 2022
Phase: N/A
Study type: Interventional

Surgical site infection (SSI) is one of the most frequent and fearsome complications in vascular surgery due to its high morbidity and mortality. In addition, SSI is one of the factors related to the development of prosthetic infection. Consequently, it represents a significant increase in hospital stay and healthcare costs. A 2021 meta-analysis on groin SSI prevention strategies in arterial surgeries reported that using intradermal sutures could be associated with a lower SSI rate. The published results from a single-center retrospective study comparing SSI rates before and after implementing an SSI prevention protocol also suggest better outcomes with intradermal suturing. This study aims to assess the SSI incidences of both skin closure techniques in vascular surgery patients undergoing femoral artery approach through a perpendicular groin skin incision.